Home Cart 0 Sign in  
X

[ CAS No. 778-82-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 778-82-5
Chemical Structure| 778-82-5
Chemical Structure| 778-82-5
Structure of 778-82-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 778-82-5 ]

Related Doc. of [ 778-82-5 ]

Alternatived Products of [ 778-82-5 ]

Product Details of [ 778-82-5 ]

CAS No. :778-82-5 MDL No. :MFCD00005635
Formula : C12H13NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :HUDBDWIQSIGUDI-UHFFFAOYSA-N
M.W : 203.24 Pubchem ID :13067
Synonyms :

Calculated chemistry of [ 778-82-5 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.25
Num. rotatable bonds : 4
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 58.97
TPSA : 42.09 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.05 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.81
Log Po/w (XLOGP3) : 2.1
Log Po/w (WLOGP) : 2.27
Log Po/w (MLOGP) : 1.69
Log Po/w (SILICOS-IT) : 3.06
Consensus Log Po/w : 2.19

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.6
Solubility : 0.507 mg/ml ; 0.00249 mol/l
Class : Soluble
Log S (Ali) : -2.61
Solubility : 0.494 mg/ml ; 0.00243 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.17
Solubility : 0.0136 mg/ml ; 0.0000668 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.84

Safety of [ 778-82-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 778-82-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 778-82-5 ]
  • Downstream synthetic route of [ 778-82-5 ]

[ 778-82-5 ] Synthesis Path-Upstream   1~18

  • 1
  • [ 778-82-5 ]
  • [ 879-37-8 ]
Reference: [1] Archiv der Pharmazie (Weinheim, Germany), 1937, vol. 275, p. 506,511
  • 2
  • [ 87-51-4 ]
  • [ 64-17-5 ]
  • [ 778-82-5 ]
YieldReaction ConditionsOperation in experiment
88%
Stage #1: With sulfuric acid In ethanol at 0℃; for 2 h; Reflux
Stage #2: With sodium hydroxide In ethanol
Ethyl 1H-indol-3-ylacetate   Indol-3-ylacetic acid (1.00 g, 5.71 mmol) was dissolved in 25 ml   ethanol and   concentrated sulphuric acid (1.0 ml, 18.4 mmol) was added. The mixture was stirred at reflux for 2 h and cooled to 0 ºC in an ice bath before neutralization with 2N   sodium hydroxide solution. The organics were evaporated under reduced pressure and the mixture was partitioned between dichloromethane and water. The aqueous phase was extracted twice with dichloromethane and the combined organic were washed with brine, dried over sodium sulphate, filtered and evaporated under reduced pressure to give 1.02 g (5.02 mmol, 88percent) of the   title compound as a brown oil. Purity 100percent.1H NMR (300 MHz, CHLOROFORM-d) δ ppm 8.09 (br. s., 1 H), 7.63 (d, J=7.69 Hz, 1 H), 7.35 (d, J=7.69 Hz, 1 H), 7.04 - 7.25 (m, 3 H), 4.17 (q, J=7.14 Hz, 2 H), 3.77 (s, 2 H), 1.26 (t, J=7.14 Hz, 3 H).UPLC/MS (3 min) retention time 1.58 min.LRMS: m/z 204 (M+1).
88%
Stage #1: at 0℃; for 2 h; Reflux
Stage #2: With sodium hydroxide In ethanol
lndol-3-ylacetic acid (1 .00 g, 5.71 mmol) was dissolved in 25 ml ethanol and concentrated sulphuric acid (1 .0 ml, 18.4 mmol) was added. The mixture was stirred at reflux for 2 h and cooled to 0 °C in an ice bath before neutralization with 2N sodium hydroxide solution. The organics were evaporated under reduced pressure and the mixture was partitioned between dichloromethane and water. The aqueous phase was extracted twice with dichloromethane and the combined organic were washed with brine, dried over sodium sulphate, filtered and evaporated under reduced pressure to give 1 .02 g (5.02 mmol, 88percent) of the title compound as a brown oil. Purity 100percent. 1 H N MR (300 MHz, CHLOROFORM-d) δ ppm 8.09 (br. s., 1 H), 7.63 (d, J=7.69 Hz, 1 H), 7.35 (d, J=7.69 Hz, 1 H), 7.04 - 7.25 (m, 3 H), 4.17 (q, J=7.14 Hz, 2 H), 3.77 (s, 2 H), 1 .26 (t, J=7.14 Hz, 3 H). UPLC/MS (3 min) retention time 1 .58 min. LRMS: m/z 204 (M+1 ).
82% for 2 h; Reflux To the solution of indole-3-acetic acid (1) (0.01 mol) in absolute ethyl alcohol (25 mL), conc. H2SO4 (2 mL) was added.
The mixture was refluxed for 2 h.
After completion of the reaction (monitored by TLC), the mixture was poured into ice-cold water.
Crude product was collected by filtration, washed with 10percent NaHCO3 solution, dried and recrystallized from ethyl alcohol to get pure product 2. Data for 2: Yellow solid, yield: 82percent, mp: 125–127 °C; IR (KBr, cm 1): v3112 (N–H, broad), 3024 (C–H, aromatic), 2962 (C–H, aliphatic), 1680 (C55O), 1560 (C55C, aromatic); 1H NMR (300 MHz, DMSO-d6): δ 11.12 (s, 1H, NH), 7.85 (s, 1H, CH of indole ring), 7.62 (d, 1H, J = 2.0 Hz, Ar–H), 7.39 (dd, 2H, J = 2.0, 8.0 Hz, Ar–H), 7.37 (d, 1H, J = 8.0 Hz, Ar–H), 4.00 (q, 2H, OCH2), 3.45 (s, 2H, CH2CO), 1.24 (t, 3H, CH3); MS: m/z 203 (M+).
78% for 3 h; Reflux General procedure: Indol-3-acetic acid or 2-pyrazine carboxylic acid (5.5 mmol) were heated under reflux for 3 h in 90 mL ethanol and 15 mL concentrated H2SO4. The solution was neutralized with saturated Na2CO3 solution and filtered. The volume was reduced in vacuum and extracted with four 30 mL aliquots of dichloromethane. The combined fractions were washed with 10 mL of water and dried over anhydrous MgSO4. The dichloromethane was removed using vacuum to yield the ethyl carboxylate derivatives, 8a mp. 1–2 °C(Lit. 1–2 °C, Vlaovic et al., 1990) or 8b mp. 46–47 °C (Lit. 48–49 °C, Yoshino et al., 2006) which crystallized on cooling.

Reference: [1] Journal of Heterocyclic Chemistry, 1986, vol. 23, p. 1777 - 1779
[2] Arzneimittel-Forschung/Drug Research, 2001, vol. 51, # 10, p. 814 - 824
[3] Patent: EP2548863, 2013, A1, . Location in patent: Paragraph 0247
[4] Patent: WO2013/10881, 2013, A1, . Location in patent: Page/Page column 95-96
[5] Chinese Chemical Letters, 2013, vol. 24, # 2, p. 127 - 130
[6] Organic Letters, 2017, vol. 19, # 9, p. 2274 - 2277
[7] Medicinal Chemistry Research, 2015, vol. 24, # 6, p. 2529 - 2550
[8] Journal of Medicinal Chemistry, 1999, vol. 42, # 4, p. 638 - 648
[9] European Journal of Medicinal Chemistry, 2012, vol. 55, p. 432 - 438
[10] Letters in Drug Design and Discovery, 2012, vol. 9, # 8, p. 780 - 788,9
[11] Tetrahedron Letters, 2015, vol. 56, # 8, p. 981 - 985
[12] Chemical Communications, 2018, vol. 54, # 65, p. 9083 - 9086
  • 3
  • [ 87-51-4 ]
  • [ 778-82-5 ]
YieldReaction ConditionsOperation in experiment
90% With sulfuric acid In ethanol; water REFERENCE EXAMPLE 12
3-Ethoxycarbonylmethylindole
A mixture of 5.0 g (28.5 mmols) of indole-3acetic acid, 250 ml of ethanol and 5 ml of conc. sulfuric acid was heated under reflux for 2 hours.
After cooling to 0° C., the mixture was neutralized with a 2 normal aqueous sodium hydroxide solution.
The solvent was evaporated under reduced pressure, and then water was added to the residue followed by extraction of the solution with chloroform.
The chloroform layer was washed with an aqueous saturated sodium chloride solution and dried over anhydrous sodium sulfate.
The solvent was evaporated under reduced pressure, and the residue was dried to afford 5.2 g (yield: 90percent) of the title compound.
NMR (CDCl3) δ (ppm): 8.10(1H, brs), 7.0-7.7(4H, m), 6.97(1H, s), 4.15(2H, q, J=7.1 Hz), 3.73(2H, s), 1.23(3H, t, J=7.1 Hz)
Reference: [1] Patent: US5053408, 1991, A,
  • 4
  • [ 19213-72-0 ]
  • [ 87-51-4 ]
  • [ 778-82-5 ]
Reference: [1] Organic Letters, 2012, vol. 14, # 8, p. 1970 - 1973
  • 5
  • [ 51079-10-8 ]
  • [ 778-82-5 ]
Reference: [1] Synthetic Communications, 1989, vol. 19, # 13-14, p. 2585 - 2594
  • 6
  • [ 623-73-4 ]
  • [ 120-72-9 ]
  • [ 778-82-5 ]
Reference: [1] Tetrahedron Letters, 2003, vol. 44, # 45, p. 8331 - 8334
[2] Chemistry - A European Journal, 2014, vol. 20, # 50, p. 16537 - 16549
[3] Journal of the Chemical Society, 1958, p. 1179,1182,4777
[4] Zhurnal Prikladnoi Khimii (Sankt-Peterburg, Russian Federation), 1956, vol. 29, p. 459,462; engl. Ausg. S. 497, 499
[5] Zhurnal Prikladnoi Khimii (Sankt-Peterburg, Russian Federation), 1956, vol. 29, p. 459,462; engl. Ausg. S. 497, 499
[6] Zhurnal Prikladnoi Khimii (Sankt-Peterburg, Russian Federation), 1956, vol. 29, p. 459,462; engl. Ausg. S. 497, 499
[7] Angewandte Chemie - International Edition, 2018, vol. 57, # 31, p. 9911 - 9915[8] Angew. Chem., 2018, vol. 130, p. 10059 - 10063,5
  • 7
  • [ 879-37-8 ]
  • [ 64-17-5 ]
  • [ 778-82-5 ]
Reference: [1] RSC Advances, 2018, vol. 8, # 9, p. 4571 - 4576
  • 8
  • [ 623-73-4 ]
  • [ 120-72-9 ]
  • [ 778-82-5 ]
  • [ 1646144-91-3 ]
  • [ 61155-69-9 ]
Reference: [1] ChemCatChem, 2014, vol. 6, # 7, p. 2047 - 2052
  • 9
  • [ 120-72-9 ]
  • [ 105-39-5 ]
  • [ 778-82-5 ]
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2002, vol. 41, # 12, p. 2647 - 2654
[2] Arzneimittel-Forschung/Drug Research, 2003, vol. 53, # 5, p. 301 - 306
  • 10
  • [ 76367-43-6 ]
  • [ 59-88-1 ]
  • [ 778-82-5 ]
Reference: [1] Journal of the American Chemical Society, 1951, vol. 73, p. 2756,2758
[2] Journal of the American Chemical Society, 1951, vol. 73, p. 5155
[3] Canadian Journal of Research, Section B: Chemical Sciences, 1935, vol. 13, p. 170,172
  • 11
  • [ 18443-04-4 ]
  • [ 778-82-5 ]
Reference: [1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1980, vol. 16, # 5, p. 501 - 506[2] Khimiya Geterotsiklicheskikh Soedinenii, 1980, # 5, p. 645 - 650
  • 12
  • [ 771-51-7 ]
  • [ 778-82-5 ]
Reference: [1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1980, vol. 16, # 5, p. 501 - 506[2] Khimiya Geterotsiklicheskikh Soedinenii, 1980, # 5, p. 645 - 650
  • 13
  • [ 96296-38-7 ]
  • [ 111-46-6 ]
  • [ 778-82-5 ]
Reference: [1] Canadian Journal of Chemistry, 1957, vol. 35, p. 1578,1580
  • 14
  • [ 1117-96-0 ]
  • [ 87-51-4 ]
  • [ 778-82-5 ]
Reference: [1] Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie, 1935, vol. 235, p. 201,213
[2] Phytochemistry (Elsevier), 1982, vol. 21, # 3, p. 525 - 530
  • 15
  • [ 31529-27-8 ]
  • [ 778-82-5 ]
Reference: [1] Canadian Journal of Chemistry, 1957, vol. 35, p. 1578,1580
  • 16
  • [ 7647-01-0 ]
  • [ 87-51-4 ]
  • [ 778-82-5 ]
Reference: [1] Journal of Organic Chemistry, 1957, vol. 22, p. 1376,1380
[2] Journal of Biological Chemistry, 1930, vol. 88, p. 659,660
  • 17
  • [ 120-72-9 ]
  • [ 623-48-3 ]
  • [ 33588-64-6 ]
  • [ 778-82-5 ]
Reference: [1] Gazzetta Chimica Italiana, 1994, vol. 124, # 6, p. 249 - 252
  • 18
  • [ 778-82-5 ]
  • [ 13721-01-2 ]
Reference: [1] Patent: WO2017/208253, 2017, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 778-82-5 ]

Esters

Chemical Structure| 1912-33-0

[ 1912-33-0 ]

Methyl 2-(1H-indol-3-yl)acetate

Similarity: 0.96

Chemical Structure| 5548-09-4

[ 5548-09-4 ]

Methyl 3-(1H-indol-3-yl)propanoate

Similarity: 0.93

Chemical Structure| 58665-00-2

[ 58665-00-2 ]

Methyl 2-(1-methyl-1H-indol-3-yl)acetate

Similarity: 0.92

Chemical Structure| 776-41-0

[ 776-41-0 ]

Ethyl 1H-indole-3-carboxylate

Similarity: 0.89

Chemical Structure| 50614-84-1

[ 50614-84-1 ]

Ethyl 1H-indole-4-carboxylate

Similarity: 0.87

Related Parent Nucleus of
[ 778-82-5 ]

Indoles

Chemical Structure| 1912-33-0

[ 1912-33-0 ]

Methyl 2-(1H-indol-3-yl)acetate

Similarity: 0.96

Chemical Structure| 5548-09-4

[ 5548-09-4 ]

Methyl 3-(1H-indol-3-yl)propanoate

Similarity: 0.93

Chemical Structure| 58665-00-2

[ 58665-00-2 ]

Methyl 2-(1-methyl-1H-indol-3-yl)acetate

Similarity: 0.92

Chemical Structure| 776-41-0

[ 776-41-0 ]

Ethyl 1H-indole-3-carboxylate

Similarity: 0.89

Chemical Structure| 1912-47-6

[ 1912-47-6 ]

2-(5-Methyl-1H-indol-3-yl)acetic acid

Similarity: 0.88